Android app Apple app link

Intra-Cellular Therapies, Inc. (ITCI) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$131.87
Day's range
$131.87

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/14/2025 Piper Sandler David Amsellem $132.00 $83.23   58.6%
10/30/2024 Goldman Sachs Corinne Jenkins $79.00 $85.47   -7.57%
09/05/2024 Piper Sandler David Amsellem $92.00 $72.42   27.04%
08/08/2024 RBC Capital Brian Abrahams $106.00 $73.63   43.96%
08/07/2024 Goldman Sachs Corinne Jenkins $74.00 $73.63   0.5%
07/22/2024 Needham Ami Fadia $100.00 $74.86   33.58%
06/25/2024 UBS Ashwani Verma $83.00 $72.42   14.61%
06/20/2024 Mizuho Securities Graig Suvannavejh $100.00 $76.06   31.48%
06/18/2024 RBC Capital Brian Abrahams $103.00 $75.48   36.46%
05/07/2024 RBC Capital Brian Abrahams $96.00 $71.21   34.81%
05/07/2024 Jefferies Andrew Tsai $105.00 $70.08   49.84%
04/23/2024 Canaccord Genuity Sumant Kulkarni $107.00 $74.54   43.55%
04/17/2024 Robert W. Baird Joel Beatty $103.00 $79.84   29.01%
04/05/2024 Needham Ami Fadia $82.00 $67.21   22.01%
06/13/2022 UBS Ashwani Verma $75.00 $53.07   41.32%

Intra-Cellular Therapies, Inc. FAQ's

Intra-Cellular Therapies, Inc. has been rated by research analysts at Piper Sandler, Goldman Sachs, RBC Capital, Needham, UBS, Mizuho Securities in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.